Purpose: Despite their age-dependent definition, febrile seizures (FS) may be observed in people of almost any age. The risk of developing unprovoked seizures after an FS is well defined. However, there are limited data about FS starting or persisting after 5 years of age. In the present study, we evaluated patients who developed FS after 5 years of age. Method: Between 2010 and 2014, we prospectively enrolled all patients with FS. We collected demographic and clinical features, radiologic images, electroencephalograms (EEGs), and results of psychomotor development tests and treatment data of the patients. The patients were grouped into two groups. Group 1 consisted of patients who had the first FS after 5 years of age, and group 2 consisted of patients in whom FS persisted after 5 years of age. Fisher's exact test and Pearson's chi-square test were used to analyse the study data and derive conclusions. Results: Sixty-four patients were enrolled, and afebrile seizure was observed in 12 (18.8%) of them. Nine (14%) patients were diagnosed to have epilepsy in their follow-up examination. Subsequent epilepsy occurrence was independent of gender, mean age, medical history of the patient, family history of epilepsy, presence of afebrile seizure, type of seizure, type of FS, duration of seizure, semiology of seizure, peak fever and EEG and magnetic resonance imaging (MRI) findings in our total cohort. There were no statistical differences between the groups with regard to the occurrence of subsequent afebrile seizure or epilepsy (p > 0.5). Conclusion: Close follow-up is important in patients with FS after the age of 5 years. These seizures are generally benign, but tend to recur and increase the risk of development of epilepsy in the patient. Further studies with a larger cohort are warranted to clarify risk factors and incidence of epilepsy in these patients.
Introduction
Febrile seizure (FS) is the most common convulsive disorder in children, and it is defined as a seizure accompanied with fever and without central nervous system infection, which occurs in infants and children of age 6 through 60 months [1] . In 50% of children, the first attack of FS occurs in the second year of life, and in 90% of children, before the age of 3 years [2] . Despite this age-dependent definition, FS may be observed in people of almost any age.
The risk of developing unprovoked seizures after an FS is estimated to be 2% to 5% [3] . The predictive risk factors for the development of epilepsy are developmental delay or an abnormal neurologic examination finding before the onset of the FS, a history of complex FS (including febrile status epilepticus), a first-degree relative with epilepsy and prolonged FS [4] . There are insufficient data about risk factors for epilepsy in children with FS occurring or persistent after 5 years of age.
The aim of our study is to identify the features and predisposing factors for the development of afebrile seizures in children with FS after 5 years of age.
Materials and methods
Between 2010 and 2014, we prospectively enrolled all patients with FS that occurred after 5 years of age. We excluded two patients and then grouped the remaining patients into two groups: group 1 consisted of patients who had their first FS after 5 years of age, and group 2 consisted of patients in whom FS persisted after 5 years of age. An FS was defined in accordance with the definition given by the American Academy of Paediatrics [1] . The demographic (age, gender, background and family history of FS and epilepsy) and clinical features (degree of fever, duration, semiology and frequency of seizures), magnetic resonance imaging (MRI) findings, electroencephalography (EEG) findings, psychomotor development test results and treatment data were evaluated and compared between the two groups. Exclusion criteria were the presence of a history of afebrile seizure, having symptomatic seizures, pathological neurologic background and progressive central nervous system illness. Prophylaxis was given to patients with more than four FS episodes and with abnormal EEG findings.
Definitions: An FS that occurred after 5 years of age was defined as late-onset FS. Persistent FS was defined as FS that occurred both before and after 5 years of age. Complex FS was defined as either focal or multiple seizures, seizures longer than 15 min or a combination of these. Simple FS was defined as a single generalised seizure within 24 h and seizures shorter than 15 min. MRI finding such as white matter lesions or hippocampal malrotations was defined as abnormal. Peak fever was categorised into a low fever group ( < 39 C) and a high fever group (!39 C). Abnormal EEG was defined as any abnormality on background activity or any epileptiform discharges.
This study was approved by the Local Ethics Committee at the Medical School of Akdeniz University. Informed consent was received from parents or guardians of the children before participation in the study.
Descriptive statistics such as frequency, percentage, mean, standard deviations median and minimum and maximum values were used. For between-group analysis, the Mann-Whitney U test was used to analyse the differences between measurements such as the total number of seizures and the mean age, and the chisquare test was used for the duration of seizures, parameters of EEG, MRI, type of seizure, type of FS, family history of FS, family history of epilepsy, consanguinity, WISC-R evaluation, history of prophylaxis, semiology of seizure, presence of afebrile seizure, prenatal history, epilepsy and gender. Risk factors for the development of afebrile seizure were evaluated in univariate analysis, and p values of less than 0.05 were considered to be statistically significant.
Results
Among 66 patients in our records, 1 patient with cortical dysplasia and 1 patient who had epileptic encephalopathy that developed during follow-up were excluded from the study. Consequently, 64 patients (26 females and 38 males) were enrolled in the study. The mean follow-up period of the patients was 1 to 3.5 years. The demographic and clinical features are shown in Table 1 .
Afebrile seizure was seen in 12 (18.8%) patients. Nine (14%) patients were diagnosed with epilepsy during the follow-up period.
Evaluation of patients with late-onset FS (group 1, n = 41)
Group 1 consisted of 19 (46%) females and 22 (54%) males, with a mean age of 8.64 AE 2.76 years. Two (5%) patients had a prenatal history of maternal smoking, and 2 (5%) patients were delivered prematurely. One patient was vaccinated with diphtheria and tetanus before the development of seizure. The parents of 8 patients (20%) had consanguinity. Among the mothers of these patients, 27 mothers graduated from primary school, 12 graduated from high school and 2 graduated from college. Among the fathers of these patients, 22 fathers graduated from primary school, 13 graduated from high school and 6 fathers graduated from college. Eight (20%) patients had a family history of FS. Seven (17%) patients had a family history of epilepsy in first-degree relatives. Thirty (73%) patients had a peak fever temperature of up to 39 C, whereas 11 patients (27%) had a peak fever temperature greater than 39 C. Among all the patients, 36 (88%) had generalised seizure and 29 (71%) had tonic-clonic seizures. The most common type of FS was simple FS (n = 29, 71%). The number of total seizures was 1.80 AE 1.73. In total, 26 (63%) patients had normal EEG findings. Twenty-eight (68%) patients had normal MRI findings. Ten (24%) patients had been receiving prophylaxis. Seven (17%) patients had afebrile seizures during follow-up, and 5 (12%) of them were diagnosed with epilepsy.
3.2. Evaluation of patients in whom FS persisted after 5 years of age (group 2, n = 23) Group 2 consisted of 7 (30%) females and 16 (70%) males, with a mean age of 8.19 AE 2.13 years. Two (9%) patients had a prenatal history of maternal smoking, and 2 (9%) patients were delivered prematurely. One patient was vaccinated with mumps-measlesrubella vaccine before the development of seizure. The parents of 5 patients (22%) were relatives. Among the mothers of these patients, 13 mothers graduated from primary school, 7 graduated from high school and 3 graduated from college. Among the fathers of these patients, 11 fathers graduated from primary school, 9 graduated from high school and 3 graduated from college. Twelve (52%) patients had a family history of FS. Five (22%) patients had a family history of epilepsy in first-degree relatives. Five (22%) patients had afebrile seizure during follow-up and were diagnosed to have epilepsy. All patients had generalised seizure, and the most observed semiology of seizure was tonic-clonic (19.83%). The most common type of FS was simple FS (21.91%). Fourteen (61%) patients had a peak fever temperature of up to 39 C, whereas 9 patients (39%) had a peak fever temperature greater than 39 C. The average number of total seizures was 4.52 AE 2.52. In total, 15 (65%) patients had normal EEG findings. Seventeen (74%) patients had normal MRI findings. Fourteen (61%) patients had been receiving prophylaxis. Five (22%) patients had afebrile seizures during their follow-up, and 4 (17%) of them were diagnosed to have epilepsy.
Comparison of the groups (Table 1)
There was no statistically significant difference between the groups in terms of mean age, gender, prenatal history, natal history, history of vaccination, consanguinity, family history of epilepsy, presence of afebrile seizure, type of seizure, semiology of seizure, EEG and MRI findings and evaluation of Wechsler Intelligence Scale for Children, Revised (WISCR). There was a statistically significant difference between the groups for family history of FS, total seizure number and administration of prophylaxis. The education level of the parents was not statistically associated with the development of epilepsy in our cohort. Peak fever also did not significantly differ between the groups. The presence of afebrile seizure was not statistically associated with the total number of seizures, type of seizure, type of FS, gender, consanguinity, family history of FS or epilepsy and psychomotor retardation (Table 2 ).
Discussion
In this study, we evaluated the risk of subsequent epilepsy in children who had the first FS after 5 years of age. Our results demonstrated that the overall risk of epilepsy following FS was 14% (n = 64). However, the number of patients was not enough to estimate the real incidence of afebrile seizures or epilepsy in our cohort. FS is the most common form of childhood seizure, and its prognosis is generally good. The risk of developing epilepsy after FS is controversial. Previous studies reported the incidence of epilepsy after FS at 2% to 5% [3, 4, 6] . Lee et al. [6] found that the incidence of subsequent epilepsy after FS was 10% in children with a mean age of 21.8 AE 13.8 months. Neligan et al. [7] demonstrated that the risk of developing epilepsy following FS was 2% to 10%. Verotti et al. [8] evaluated children with FS occurring or persistent after 5 years of age. They found that children (n = 20) with FS after 5 years of age could have a two-to three-fold risk of developing subsequent unprovoked seizures compared to children under 5 years of age with seizures and fever. Pavone et al. [9] found that the risk of epilepsy in children who have FS after 6 years of age was 15.8% in a 5-year follow-up period. Our results are consistent with the literature.
The pathogenetic mechanism or a cause-effect relationship between FS and epilepsy is unclear. Some recent studies have pointed to a genetic relationship between FS and epilepsy [10, 11] . Similarly, Burgess et al. [12] discussed some of the potential mechanisms that have been recently revealed to link mutant ion channel genes to generalised epilepsy with febrile seizures plus (GEFS+). Vestergaard et al. [4] reported that siblings of children with FS frequently display epilepsy, even if they did not experience FS. Seinfeld et al. [13] published a study on twins and showed that a twin with febrile status epilepticus was at the highest risk of developing epilepsy. In addition to genetic predispositions, the FEBSTAT MRI [14] study also showed that acute febrile status epilepticus might cause acute hippocampal injury.
Our study showed that the incidence of subsequent epilepsy after FS was higher and it is independent of gender, mean age, prenatal history, natal history, history of vaccination, consanguinity, family history of epilepsy, presence of afebrile seizure, type of seizure, type of FS, duration of seizure, semiology of seizure, education level of parents, peak fever and EEG and MRI findings in our total cohort. One of the main limitations of this study is the small sample size. Therefore, we cannot confirm that the aforementioned factors definitely do not increase the risk of epilepsy. Previous studies have shown that the risk factors for unprovoked seizures after FS are the onset of FS at an early age, complex FS, neurodevelopmental abnormalities, abnormal EEG, and a family history of epilepsy [15, 16] . Our results demonstrated that prolonged FS (>15 min) is not a risk factor for developing epilepsy. Similarly, Sapir et al. [17] reported that none of their patients with prolonged FS later developed epilepsy. A recent study concluded that prolonged FS is the result of a previous insult to the hippocampus and not the cause of it [18] . On the other hand, neuroimaging and animal studies demonstrated acute swelling and oedema of the hippocampus and that hyperthermia-induced seizures may cause long-lasting modifications of the channels, synapses and neuronal networks within the hippocampus, leading to sustained dysfunction of these cells and a decreased seizure threshold after prolonged FS [19] [20] [21] . 
Conclusion
Generally, childhood FS is benign and self-limiting. Epilepsy is the primary serious complication of FS, especially if the first FS occurs at an uncommon age. We emphasise that FS can occur or persist after 5 years of age and may be a warning sign of epilepsy; thus, these children may need special attention. However, further studies with a larger cohort are warranted to clarify the risk of epilepsy in these patients.
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